Bank of New York Mellon’s PhenomeX Inc. Common Stock CELL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-23,033
| Closed | -$23K | – | 4454 |
|
|
2023
Q3 | $23K | Hold |
23,033
| – | – | ﹤0.01% | 4240 |
|
|
2023
Q2 | $11.3K | Sell |
23,033
-295,693
| -93% | -$242K | ﹤0.01% | 4333 |
|
|
2023
Q1 | $370K | Buy |
318,726
+33,955
| +12% | +$62.1K | ﹤0.01% | 3651 |
|
|
2022
Q4 | $763K | Buy |
284,771
+25,006
| +10% | +$65.9K | ﹤0.01% | 3330 |
|
|
2022
Q3 | $743K | Buy |
259,765
+37,044
| +17% | +$158K | ﹤0.01% | 3353 |
|
|
2022
Q2 | $1.11M | Buy |
222,721
+73,518
| +49% | +$385K | ﹤0.01% | 3168 |
|
|
2022
Q1 | $1.06M | Buy |
149,203
+2,570
| +2% | +$21.3K | ﹤0.01% | 3273 |
|
|
2021
Q4 | $2.67M | Sell |
146,633
-41,379
| -22% | -$893K | ﹤0.01% | 2819 |
|
|
2021
Q3 | $3.68M | Buy |
188,012
+38,363
| +26% | +$1.46M | ﹤0.01% | 2644 |
|
|
2021
Q2 | $6.71M | Buy |
149,649
+98,193
| +191% | +$4.55M | ﹤0.01% | 2355 |
|
|
2021
Q1 | $2.58M | Buy |
51,456
+8,867
| +21% | +$605K | ﹤0.01% | 2774 |
|
|
2020
Q4 | $3.81M | Buy |
42,589
+19,183
| +82% | +$1.61M | ﹤0.01% | 2492 |
|
|
2020
Q3 | $1.79M | Buy |
+23,406
| New | +$1.49M | ﹤0.01% | 2735 |
|
Bank of New York Mellon's CELL Position: Q4 2023 in Review
Bank of New York Mellon sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 23,033 shares — an estimated $23K sold.
Bank of New York Mellon first reported a position in CELL in Q3 2020 and held it in 13 quarters. The position peaked at $6.71M in Q2 2021. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.
- Bank of New York Mellon reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Bank of New York Mellon sold 23,033 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $23K.
- Bank of New York Mellon first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 13 quarters.
- Bank of New York Mellon's PhenomeX Inc. Common Stock position peaked at $6.71M in Q2 2021.
- 0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.
Based on Bank of New York Mellon's 13F filing for Q4 2023, filed 29 Jan 2024.